S
Scott H. Sicherer
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 426
Citations - 36246
Scott H. Sicherer is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Food allergy & Peanut allergy. The author has an hindex of 93, co-authored 394 publications receiving 31981 citations. Previous affiliations of Scott H. Sicherer include Johns Hopkins University & Mount Sinai Hospital.
Papers
More filters
Journal ArticleDOI
386 Non-resolution of infantile food protein-induced enterocolitis syndrome (FPIES)
Journal ArticleDOI
Egg Oral Immunotherapy (OIT) Induces Clinical Desensitization in a Double-Blind, Placebo-Controlled (DBPC) Trial in Egg Allergic Children from the Consortium of Food Allergy Research (CoFAR)
Stacie M. Jones,David Fleischer,Scott H. Sicherer,Robert A. Wood,Robert Lindblad,D. Stablein,A.H. Liu,Wayne G. Shreffler,Donald Y.M. Leung,Hugh A. Sampson,A.W. Burks +10 more
Journal ArticleDOI
Protocol Design and Synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Children and Adults (OUtMATCH)
Robert A. Good,R. Sharon Chinthrajah,Amanda K. Rudman Spergel,Denise C Babineau,Scott H. Sicherer,Edwin H. Kim,Wayne G. Shreffler,Stacie M. Jones,Donald Y.M. Leung,Brian P. Vickery,J. Andrew Bird,Jonathan M. Spergel,Mike Kulis,Ahmar Iqbal,Derrick Kaufman,Dale T. Umetsu,Monica Ligueros-Saylan,Alkaz Uddin,Robert B. Fogel,Stephanie Lussier,Kim Mudd,J. Poyser,Martin J. Macphee,Maria J. Veri,Wendy Davidson,Sanaz D Hamrah,Andrew Long,Alkis Togias +27 more
TL;DR: In this paper , the authors described a phase 3 study on treatment of patients with multiple food allergies with omalizumab, which was developed as a collaboration between the Consortium for Food Allergy Research, the National Institute of Allergy and Infectious Diseases, and 2 industry sponsors (Genentech and Novartis).
Journal ArticleDOI
Impact of granulocyte contamination on PBMC integrity of shipped blood samples: Implications for multi-center studies monitoring regulatory T cells.
Charuta Agashe,David Y. Chiang,Alexander Grishin,Madhan Masilamani,Stacie M. Jones,Robert A. Wood,Scott H. Sicherer,A. Wesley Burks,Donald Y.M. Leung,Peter Dawson,Hugh A. Sampson,M. Cecilia Berin +11 more
TL;DR: Routine incorporation of a granulocyte depletion step during PBMC isolation is recommended prior to downstream immune monitoring in blood with next-day processing, as it has reduced assay failure due to loss of sample integrity.
Journal ArticleDOI
The Journal of Allergy and Clinical Immunology: In Practice — 2016 Year in Review
TL;DR: This review summarized articles on the topics of asthma, rhinitis/rhinosinusitis, food allergy, anaphylaxis, drug allergy, urticarial/angioedema, eosinophilic disorders, and immunodeficiency published in 2016 in The Journal of Allergy and Clinical Immunology: In Practice.